Drug Approval | November 19, 2022
Strides receives USFDA approval for Potassium Chloride Oral Solution
The approval further strengthens the Potassium Chloride franchise for the company.
The approval further strengthens the Potassium Chloride franchise for the company.
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Prime Minister Narendra Modi attended an event marking the 100th robotic-assisted surgical system installation at U. N. Mehta Institute of Cardiology, Ahmedabad.
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Ties up with Denmark’s Vestfrost Solutions, to cater to the unique needs of the Indian market
Subscribe To Our Newsletter & Stay Updated
